Alnylam Submits a Clinical Trial Authorization Application for Their NASH Treatment- August 11, 2020
PODCAST: WAIT, HOW DO YOU SPELL THAT?
LATEST PATIENT WORTHY ARTICLES
As reported in Parkinson’s News Today, a new study published in Family Medicine and Community Health has looked into the relationship between concussions and certain other
A blood test that gives a more accurate diagnosis of Alzheimer’s disease was announced at the July 2020 International Conference of the Alzheimer’s Association.
Because of COVID-19, many meetings and events have been moved online – but that does not mean the learning has stopped. During the virtual
Ovid Therapeutics and Columbia University are Working on a Treatment for KIF1A Associated Neurological Disorder
According to a story from GlobeNewswire, the biopharmaceutical company Ovid Therapeutics Inc. and Columbia University have recently entered a collaborative partnership that will be focused
- August 13 @ 2:00 pm - 4:00 pm
- August 19 @ 5:30 pm - 7:30 pm
- August 22 @ 6:30 pm - 8:30 pm
- August 24 - August 26
- August 27 @ 4:00 pm - 6:00 pm